PRVB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 20, 2021 in the Class Action Filed on Behalf of Provention Bio, Inc. Limited ShareholdersNewsfile Corp • 07/15/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Provention Bio, Inc. (PRVB)PRNewsWire • 07/15/21
TUESDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/15/21
Rosen, Global Investor Counsel, Encourages Provention Bio, Inc. Investors to Secure Counsel Before Important July 20 Deadline in Securities Class Action - PRVBNewsfile Corp • 07/14/21
Teplizumab Awarded Innovation Passport in the United Kingdom (UK) for the Delay of Onset of Clinical Type 1 Diabetes in At-risk IndividualsPRNewsWire • 07/12/21
Rosen, Global Investor Counsel, Encourages Provention Bio, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important July 20 Deadline in Securities Class Action - PRVBNewsfile Corp • 07/09/21
SHAREHOLDER ALERT: Investigation of Provention Bio Announced by Holzer & Holzer, LLCNewsfile Corp • 07/06/21
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving TodayBenzinga • 07/06/21
Provention Bio's Teplizumab Application Receives CRL For Type-1 Diabetes; Stock DropsBenzinga • 07/06/21
Provention Bio Receives Complete Response Letter (CRL) to Biologics License Application (BLA) for Teplizumab for the Delay of Clinical Type 1 Diabetes (T1D) in At-risk IndividualsPRNewsWire • 07/06/21
ROSEN, A LEADING LAW FIRM, Encourages Provention Bio, Inc. Investors to Secure Counsel Before Important July 20 Deadline in Securities Class Action - PRVBPRNewsWire • 07/02/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Provention Bio, Inc. Investors to Secure Counsel Before Important July 20 Deadline in Securities Class Action - PRVBNewsfile Corp • 06/29/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/29/21
Implied Volatility Surging for Provention Bio (PRVB) Stock OptionsZacks Investment Research • 06/28/21
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Provention Bio, Inc. (PRVB) InvestorsPRNewsWire • 06/23/21
ROSEN, A TOP RANKED FIRM, Encourages Provention Bio, Inc. Investors to Secure Counsel Before Important July 20 Deadline in Securities Class Action - PRVBNewsfile Corp • 06/21/21
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Provention Bio, Inc. (PRVB)PRNewsWire • 06/21/21
ROSEN, A TOP RANKED LAW FIRM, Encourages Provention Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PRVBPRNewsWire • 06/18/21
PRVB Investor Notice: Rosen, Leading Trial Attorneys, Encourages Provention Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PRVBNewsfile Corp • 06/15/21
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/09/21
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/08/21
